Distinguished in Retinal Detachment

Teresio Avitabile

Ct, 
Catania, IT 
Distinguished in Retinal Detachment
Ct, 
Catania, IT 
OverviewLocationsClinical Research

Overview

Teresio Avitabile practices in Catania, Italy. Avitabile is rated as a Distinguished expert by MediFind in the treatment of Retinal Detachment. Their top areas of expertise are Retinal Detachment, Uveal Melanoma, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Their clinical research consists of co-authoring 171 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 29 articles in the study of Retinal Detachment.

Locations

Ct, Catania, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
Enrollment Status: Completed
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 3

171 Total Publications

FACTORS INFLUENCING THE NUMBER OF ANTI-VEGF INJECTIONS IN MYOPIC CHOROIDAL NEOVASCULARIZATION: A Multicenter Study.
FACTORS INFLUENCING THE NUMBER OF ANTI-VEGF INJECTIONS IN MYOPIC CHOROIDAL NEOVASCULARIZATION: A Multicenter Study.
Journal: Retina (Philadelphia, Pa.)
Published: July 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Avitabile's expertise for a condition
ConditionClose
View All 15 Advanced Conditions
View All 32 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile